These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 22778866)
41. Cost-Effectiveness Analysis of Qsymia for Weight Loss. Finkelstein EA; Kruger E; Karnawat S Pharmacoeconomics; 2015 Jul; 33(7):699-706. PubMed ID: 24986038 [TBL] [Abstract][Full Text] [Related]
42. Safety assessment of combination therapies in the treatment of obesity: focus on naltrexone/bupropion extended release and phentermine-topiramate extended release. Halpern B; Mancini MC Expert Opin Drug Saf; 2017 Jan; 16(1):27-39. PubMed ID: 27732121 [TBL] [Abstract][Full Text] [Related]
43. Health-related quality of life in two randomized controlled trials of phentermine/topiramate for obesity: What mediates improvement? Kolotkin RL; Gadde KM; Peterson CA; Crosby RD Qual Life Res; 2016 May; 25(5):1237-44. PubMed ID: 26446094 [TBL] [Abstract][Full Text] [Related]
44. Long-Term Efficacy and Safety of Anti-Obesity Treatment: Where Do We Stand? Tak YJ; Lee SY Curr Obes Rep; 2021 Mar; 10(1):14-30. PubMed ID: 33410104 [TBL] [Abstract][Full Text] [Related]
45. Phentermine plus topiramate in the treatment of obesity. Cohen PA Lancet; 2011 Jul; 378(9786):126; author reply 126-7. PubMed ID: 21742168 [No Abstract] [Full Text] [Related]
46. In brief: Phentermine (Lomaira) for weight loss. Med Lett Drugs Ther; 2016 Dec; 58(1509):158. PubMed ID: 27906152 [No Abstract] [Full Text] [Related]
47. A Comparison of New Pharmacological Agents for the Treatment of Obesity. Nuffer W; Trujillo JM; Megyeri J Ann Pharmacother; 2016 May; 50(5):376-88. PubMed ID: 26887340 [TBL] [Abstract][Full Text] [Related]
48. Nonincretin drugs in later-stage development. Zimmerman MP; Mehr SR Am J Manag Care; 2014 Jan; 20(1 Spec No.):E2. PubMed ID: 25618226 [No Abstract] [Full Text] [Related]
49. Overview of new antiobesity drugs. Hainer V Expert Opin Pharmacother; 2014 Oct; 15(14):1975-8. PubMed ID: 25100293 [TBL] [Abstract][Full Text] [Related]
50. The pharmacological and surgical management of adults with obesity. Ryan DH J Fam Pract; 2014 Jul; 63(7 Suppl):S21-6. PubMed ID: 25198216 [No Abstract] [Full Text] [Related]
51. Diet drugs Belviq and Qsymia receive FDA approval: what dentists need to know. Wynn RL Gen Dent; 2013; 61(1):11-3. PubMed ID: 23302354 [No Abstract] [Full Text] [Related]
52. New pharmacological approaches for obesity management. Rueda-Clausen CF; Padwal RS; Sharma AM Nat Rev Endocrinol; 2013 Aug; 9(8):467-78. PubMed ID: 23752772 [TBL] [Abstract][Full Text] [Related]
54. Clinical pharmacotherapy for obesity: current drugs and those in advanced development. Halford JC Curr Drug Targets; 2004 Oct; 5(7):637-46. PubMed ID: 15473253 [TBL] [Abstract][Full Text] [Related]
55. New developments in the pharmacologic treatment of obesity. Fantasia HC Nurs Womens Health; 2013; 17(1):53-62. PubMed ID: 23399013 [TBL] [Abstract][Full Text] [Related]
56. Cardiometabolic Disease Staging Predicts Effectiveness of Weight-Loss Therapy to Prevent Type 2 Diabetes: Pooled Results From Phase III Clinical Trials Assessing Phentermine/Topiramate Extended Release. Guo F; Garvey WT Diabetes Care; 2017 Jul; 40(7):856-862. PubMed ID: 28455281 [TBL] [Abstract][Full Text] [Related]
57. Lorcaserin, phentermine topiramate combination, and naltrexone bupropion combination for weight loss: the 15-min challenge to sort these agents out. Citrome L Int J Clin Pract; 2014 Dec; 68(12):1401-5. PubMed ID: 25418525 [No Abstract] [Full Text] [Related]
59. [Cutting-edge of medicine; the prospects of novel anti-obesity drugs]. Ueno H; Nakazato M Nihon Naika Gakkai Zasshi; 2014 Mar; 103(3):753-9. PubMed ID: 24796150 [No Abstract] [Full Text] [Related]
60. Effects of liraglutide plus phentermine in adults with obesity following 1 year of treatment by liraglutide alone: A randomized placebo-controlled pilot trial. Tronieri JS; Wadden TA; Walsh OA; Berkowitz RI; Alamuddin N; Gruber K; Leonard S; Chao AM Metabolism; 2019 Jul; 96():83-91. PubMed ID: 30902750 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]